Study of Hepatitis B core Antibody (HBcAb) among Pregnant women and their Newborn at Delivery at Umaru Shehu Ultra-Modern Hospital Maiduguri, Borno State Nigeria
DOI:
https://doi.org/10.54987/jobimb.v10i1.717Keywords:
Hepatitis B core Antibody (HBcAb), Pregnant women, Newborn, Umaru Shehu Ultra-Modern Hospital, NigeriaAbstract
Hepatitis B virus infection (HBV) is a worldwide Health problem that has destroyed the lives of people that were predisposed to viral attack, with a significant public implication. The main objectives of this study are to determine the overall prevalence of Hepatitis B Core antibodies in mothers, the overall prevalence of Hepatitis B Core antibodies in their newborns, the prevalence according to the age of mothers, the prevalence according to the gender of the newborns and maternal transfer of HBcAb from the mother to their newborns. A total of 101 plasma were collected from pregnant women and their newborns in the delivery room from the maternity ward at the Umaru Shehu ultra-modern Hospital Maiduguri, Borno state, Nigeria. Pro-med gold Rapid Diagnostic test kits from the United State of America (USA) was used for the detection of Hepatitis B core antibody. Of the 101, mothers and 101 newborns that were assayed for, mothers within the age range of 17 – 40 years with mean ± SD age of 25.9 (±5.2) years, having an overall prevalence of 28.7% for HBcAb of the mothers observed from the result analysis of plasma from pregnant women attending an antenatal program at the Umaru Shehu ultra-modern Hospital Maiduguri, Borno state, Nigeria. Hepatitis B Virus remains a threat to be causing public Health Havoc Globally, this research has revealed that a significant proportion of 72 (71.3%) of the study population is at risk of being infected with HBV since they have no detectable marker of infection or immunity against the virus. Therefore, there is a need for regular and prompt screening of pregnant women for HBV infection and vaccination of those at risk.
References
World Health Organisation (WHO). Who encourages countries to act now to reduce deaths from viral hepatitis Online; 2006.World Health Organization (WHO).2016.
Hyun MH, Lee YS, Kim JH, Je JH, Yoo YJ, Yeon JE, Byun KS. Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus. Aliment Pharmacol Ther. 2017;45(12):1493-1505.
Chan SL, Wong VW, Qin S, Chan HL. Infection and Cancer: The Case of Hepatitis B. J Clin Oncol. 2016;34(1):83-90.
Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, et al.. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR. Recomm Rep. 2013;62(RR-10): 1-19.
Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112-25.
Peters MG. Hepatitis B Virus Infection: What Is Current and New. Topic Antiviral Med. 2019;26(4):112-116.
Zuckerman AJ. Hepatitis Viruses. In Baron S, et al. (eds.). Baron's Medical Microbiology (4th ed.). University of Texas Medical Branch. ISBN 978-0-9631172-1-2. 1996
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: New estimates of age specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:22129
Roche B, Samuel D. The difficulties of managing severe hepatitis B virus reactivation. Liver Int. 2011;31(Suppl 1):104-110.
Watashi K, Wakita T. Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism. Cold Spring Harb Perspect Med. 2015;5(8):a021378..
Bruss V. Hepatitis B virus morphogenesis. World J Gastroenterol. 2007;13(1): 65-73.
Ben Guarino. New strains of hepatitis B virus discovered in ancient human remains. The Washington Post. Retrieved 9 January 2018.
Willey JM, Sherwood LM, Woolverton CJ, Editors. Human diseases caused by viruses and prions, direct contact diseases: Viral hepatitis. In: Prescott's Microbiology. International Edition. Eight Edition. New York: The McGraw Hill companies.2011;919-921.
Hundie GB, Stalin Raj V, Gebre Michael D, Pas SD, Koopmans MP, Osterhaus AD, et al.. A novel hepatitis B virus subgenotype D10 circulating in Ethiopia. J Viral Hep. 2017;24(2):163-173.
Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev. 2014;(11): CD007879.
Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG. HBV pathogenesis in animal models: Recent advances on the role of platelets. J Hepatology. 2007;46(4):719-726
Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8(3):3895-3932.
Oyinloye, D.N. Bukbuk and F.A. Sanda. Surveillance of Hepatitis B Biomakers in Borno state, Nigeria. J Adv Med Med Res. 2018;28(10):1-8.
Villa E, Fattovich G, Mauro A, Pasino M. Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. Digest Liver Dis. 2011;43(Suppl 1):S8-14.
Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antivir Ther. 2010;15:25-33.
T, Masuda G, Ajisawa A, Hiruma K, Tsuda F, Nishizawa T, Takahashi M, Okamoto H. Characterization of seven genotypes (A to E, G and H) of hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1. J Medic Virol. 2005;76(1):24-32.
Schroth RJ, Hitchon CA, Uhanova J, Noreddin A, Taback SP, Moffatt ME, Zacharias JM. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev. 2004;2004(3):CD003775.
Bell SJ, Nguyen T. The management of hepatitis B. Aust Prescr. 2009;32(4):99-104.
Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus (HBV) quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl. 2011;17(8):955-62.
Mastroianni CM, Lichtner M, Citton R, Del Borgo C, Rago A, Martini H, Cimino G, Vullo V. Current trends in management of hepatitis B virus reactivation in the biologic therapy era. World J Gastroenterol. 2011;17(34): 3881-7.
Pramoolsinsup C. Management of viral hepatitis B. J Gastroenterol Hepatol. 2002;17(Suppl):S125-45.
Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261-83.
Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis. J. Viral Hepat. 2008;15(2):89-102.
Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li X, Sun W, Zhao X, Yang X, Zhang L, Lu W, Teng J, An Y. Breastfeeding of Newborns by Mothers Carrying Hepatitis B Virus: A Meta-analysis and Systematic Review. Arch Pediatr Adolesc Med. 2011;165 (9): 837-846.
GBD 2015 Mortality and Causes of Death, Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-1544.
Zhong-Liao Fang, Caroline A Sabin, Bai-Qing Dong, Shao-Chao Wei, Qin-Yan Chen, Kong-Xiong Fang, Jin-Ye Yang, Xue-Yan Wang, Tim J Harrison. The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: A longitudinal analysis. J Hepatol. 2008;50(2):273-280.
Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507-39.
Tong S, Li J, Wands JR. Carboxypeptidase D is an avian hepatitis B virus receptor. J Virol. 1999;73(10):8696-8702.
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet.2016;388(10053):1545-1602.
GBD 2017 Disease and Injury Incidence and Prevalence, Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-1858.
-Lai CL, Yuen MF. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Internal Medic. 2007;147(1):58-61.
Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012;1: e00049.
Ifeorah, A. S. Bakarey, M. O. Adewumi, T. O. C. Faleye, A. Akere, C. E. Omoruyi, A. O. Ogunwale, C.C. Uttah, M. A. Oketade & J. A. Adeniji. Patterns of serologic markers of hepatitis B virus infection and the risk of transmission among pregnant women in southwestern Nigeria. J Immuno Immunochem. 2017;38(6):639-651.
Mühlemann B, Jones TC, Damgaard PB, Allentoft ME, Shevnina I, Logvin A, et al. Ancient hepatitis B viruses from the Bronze Age to the Medieval period. Nature. 2018;557(7705):418-423.
Taylor JM. Hepatitis delta virus. Virology. 2006;344(1):71-76.
Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol. 2007;13(1):22-38.
Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl): S13-21.
Paraskevis, Dimitrios. Dating the Origin and Dispersal of Hepatitis B Virus Infection in Humans and Primates. Hepatology. 2013;(3): 908-16.
Nongo BH, Agida TE,Oghenebuk U, Tahir Y. Seroprevalence of hepatitis B virus among antenatal attendees at the University of Abuja Teaching Hospital, Nigeria. Ann Niger Medic. 2016;10(2):58-62.
Keats JJ, R Fonseca, M Chesi, R Schop, A Baker, WJ Chng, S Van Wier. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;14;3(3):CD004905.
Patterson Ross Z, Klunk J, Fornaciari G, Giuffra V, Duchêne S, Duggan AT, et al.. The paradox of HBV evolution as revealed from a 16th century mummy. PLOS Pathogens. 2018;14(1):e1006750.
Guerrieri F, Belloni L, D'Andrea D, Pediconi N, Le Pera L, Testoni B, et al. Genome-wide identification of direct HBx genomic targets. BMC Genomics. 2017;18(1):184.
Buti M, Rodriguez-Frias F, Jardi R, Esteban R. Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes. J Clin Virol. 2005;34Suppl1:S79-82.
Bao-Ming Liu, Tong Li, Jie Xu, Xiao-Guang Li, Jian-Ping Dong, Ping Yan, Jing-Xian Yang, Ling Yan, Zhi-Yong Gao, Wen-Peng Li, Xie-Wen Sun, Yu-Hua Wang, Xiu JuanJiao, Chun-Sheng Hou, Hui Zhuang. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. Antivir Res. 2010;85(3):512-519.
Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15(46): 5761-5769.
Davis, Jane. Molecular Epidemiology of Hepatitis B in the Indigenous People of Northern Australia. Gastroenterol Hepatol. 2013;(7):1234-1241.
Alberti A, Caporaso N. HBV therapy: guidelines and open issues. Digest Liver Dis. 2011;43(Suppl 1):S57-63.
J, Nassal M. Hepatitis B virus replication. World J Gastroenterol. 2007;13(1):48-64.
Bonacini, Maurizio, MD. Hepatitis B Reactivation. University of Southern California Department of Surgery. Archived from the original on 27 November 2008. Retrieved 24 January 2009
Chu CM, Liaw YF. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology. 133 (5): 1458-65. doi:10.1053/j.gastro.2007.08.039. PMID 17935720.
Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995;38(1-2):24-34.
Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev. 2005;(2):CD000100.
Fairley CK, Read TR. Vaccination against sexually transmitted infections. Curr Opin Infect Dis. 2012;25(1):66-72.
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;19;(2):CD004790..
Bonino F, Chiaberge E, Maran E, Piantino P. Serological markers of HBV infectivity. Ann Ist Super Sanita. 1987;24(2):217-23.
Eke AC, Eleje GU, Eke UA, Xia Y, Liu J. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database Syst Rev. 2017;2(2):CD008545.
Henrietta Oneh Aba and Maryam Aminu. Seroprevalence of Hepatitis B virus serological markers among pregnant Nigerian women. Ann Afr Med. 2016;15(1):20-27.
Littlejohn M, Locarnini S, Yuen L. Origins and Evolution of Hepatitis B Virus and Hepatitis D Virus. Cold Spring Harb Perspect Med. 2016;6(1): a021360.
Kerkar N. Hepatitis B in children: complexities in management. Ped Transplant. 2005;9(5):685-691.
Buti M, Rodriguez-Frias F, Jardi R, Esteban R. Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes. J Clin Virol. 2005;34Suppl 1:S79-82.
Balakrishnan L, Milavetz B. Epigenetic regulation of viral biological processes. Viruses. 2017;9(11):346.
Araujo, NM. Hepatitis B virus intergenotypic recombinants worldwide: An overview. Infect Genet Evol. 2015;36:500-510.
Gan SI, Devlin SM, Scott-Douglas NW, Burak KW. Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection. Can J Gastroenterol. 2005;19(10):625-629.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Biochemistry, Microbiology and Biotechnology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
